Literature DB >> 12556650

High prevalence of target organ damage in young, African American inner-city men with hypertension.

Wendy S Post1, Martha N Hill, Cheryl R Dennison, James L Weiss, Gary Gerstenblith, Roger S Blumenthal.   

Abstract

Young, urban, African American men are at particularly high risk of hypertension and its cardiovascular complications. Left ventricular hypertrophy and renal dysfunction are manifestations of target organ damage from hypertension that predict adverse cardiovascular events. The subjects of this study were 309 African American men, age 18-54 years, with hypertension, residing in inner-city Baltimore. Echocardiograms, electrocardiograms, serum creatinine, and the urinary albumin-creatinine ratio were obtained to evaluate hypertensive target organ damage. Fifty-three percent of the men reported use of antihypertensive medications, of whom 80% were on monotherapy. Calcium channel blockers were used most frequently. The mean echocardiographic left ventricular mass was 211+/-68 g, with a prevalence of echocardiographic left ventricular hypertrophy of 30%. There were 14 men (5%) with extremely high left ventricular mass, >350 grams. Left ventricular systolic dysfunction was seen in 9% of the men with uncontrolled hypertension, and none of the men with controlled hypertension (p=0.02). Renal dysfunction was found in 12% of the subjects, and microalbuminuria or gross proteinuria in 34%. The authors conclude that there is a high prevalence of cardiac and renal abnormalities in inner-city African American men with hypertension, especially in men on antihypertensive therapy with uncontrolled hypertension. It is imperative that cost-effective medications and culturally acceptable health care delivery programs be developed, tested, and integrated into health systems, with strategies specifically relevant to this high-risk population, to decrease the largely preventable morbidity and mortality associated with hypertension. Copyright 2003 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12556650      PMCID: PMC8101811          DOI: 10.1111/j.1524-6175.2003.01246.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  32 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  End-stage renal disease in US minority groups.

Authors:  H I Feldman; M J Klag; A P Chiapella; P K Whelton
Journal:  Am J Kidney Dis       Date:  1992-05       Impact factor: 8.860

Review 3.  Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.

Authors:  S Bianchi; R Bigazzi; V M Campese
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

4.  Etiology and characteristics of congestive heart failure in blacks.

Authors:  J Mathew; S Davidson; L Narra; T Hafeez; R Garg
Journal:  Am J Cardiol       Date:  1996-12-15       Impact factor: 2.778

5.  Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study.

Authors:  M L Daviglus; Y Liao; P Greenland; A R Dyer; K Liu; X Xie; C F Huang; R J Prineas; J Stamler
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

6.  Trends in acute myocardial infarction and coronary heart disease death in the United States.

Authors:  R F Gillum
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

7.  The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.

Authors:  I W Hammond; R B Devereux; M H Alderman; E M Lutas; M C Spitzer; J S Crowley; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

8.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

Authors:  N B Shulman; C E Ford; W D Hall; M D Blaufox; D Simon; H G Langford; K A Schneider
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

9.  Understanding and addressing racial disparities in health care.

Authors:  D R Williams; T D Rucker
Journal:  Health Care Financ Rev       Date:  2000

Review 10.  Pre-clinical cardiovascular disease and surrogate end-points in hypertension: does race influence target organ damage independent of blood pressure?

Authors:  R B Devereux; P M Okin; M J Roman
Journal:  Ethn Dis       Date:  1998       Impact factor: 2.006

View more
  9 in total

1.  Racial Disparity in Cognitive and Functional Disability in Hypertension and All-Cause Mortality.

Authors:  Ihab Hajjar; Whitney Wharton; Wendy J Mack; Allan I Levey; Felicia C Goldstein
Journal:  Am J Hypertens       Date:  2015-07-01       Impact factor: 2.689

2.  Prevalence of hypertension and diabetes among Ethiopian adults.

Authors:  Lemba D Nshisso; Angela Reese; Bizu Gelaye; Sebelewengel Lemma; Yemane Berhane; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2012-06-05

3.  Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.

Authors:  Keith C Norris; Tom Greene; Joel Kopple; Janice Lea; Julia Lewis; Mike Lipkowitz; Pete Miller; Annie Richardson; Stephen Rostand; Xuelei Wang; Lawrence J Appel
Journal:  J Am Soc Nephrol       Date:  2006-09-07       Impact factor: 10.121

4.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

5.  Social and Environmental Risk Factors for Hypertension in African Americans.

Authors:  Selina Rahman; Howard Hu; Eileen McNeely; Saleh M M Rahman; Nancy Krieger; Pamela Waterman; Junenette Peters; Cynthia Harris; Cynthia H Harris; Deborah Prothrow-Stith; Brian K Gibbs; Perry C Brown; Genita Johnson; Angela Burgess; Richard D Gragg
Journal:  Fla Public Health Rev       Date:  2008-01-01

6.  Pseudophaeochromocytoma in two young Africans.

Authors:  O E Okosieme; R E Morse
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

7.  High prevalence and low awareness of hypertension in a market population in enugu, Nigeria.

Authors:  Ifeoma I Ulasi; Chinwuba K Ijoma; Basden J C Onwubere; Ejikeme Arodiwe; Obinna Onodugo; Christian Okafor
Journal:  Int J Hypertens       Date:  2011-01-27       Impact factor: 2.420

8.  Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care).

Authors:  Athanasia Papazafiropoulou; Efstathios Skliros; Alexios Sotiropoulos; Christos Papafragos; Aristofanis Gikas; Ourania Apostolou; Hariklia Kaliora; Charalambos Tountas
Journal:  BMC Fam Pract       Date:  2011-07-14       Impact factor: 2.497

Review 9.  Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings.

Authors:  Kanokwan Bunsawat; Gregory J Grosicki; Soolim Jeong; Austin T Robinson
Journal:  Prog Cardiovasc Dis       Date:  2022-04-29       Impact factor: 11.278

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.